Stock 6160 BEIGENE, LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart BeiGene, Ltd. Hong Kong S.E.

Equities

6160

KYG1146Y1017

Delayed Hong Kong S.E.
Other stock markets
 10:52:57 2024-05-23 pm EDT 		5-day change 1st Jan Change
92.2 HKD -5.73% Intraday chart for BeiGene, Ltd. -11.20% -16.44%
May. 21 Glenmark Pharma Arm to Market Two Beigene Cancer Drugs in India MT
May. 14 BeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 24.69B -
ARGENX SE Stock argenx SE
 21.97B -
GENMAB A/S Stock Genmab A/S
 19.27B
  1. Stock Market
  2. Equities
  3. BGNE Stock
  4. 6160 Stock
  5. Charts BeiGene, Ltd.
  6. Sector Chart